Who owns ACHILLES THERAPEUTICS PLC?
- Ticker: ACHL
- CUSIP Number: 00449l102
Tip: Access positions for across all investors
Analyze quarterly positions in Achilles Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Achilles Therapeutics stock
Who bought or sold ACHILLES THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Syncona Portfolio | 11M | $9.9M | 0% | Dec 2023 |
|
| Fcpm Iii Services B.v. | 2.4M | $2.1M | 100% | Dec 2023 |
|
| Artal Group | 2.3M | $2.0M | 0% | Dec 2023 |
|
| Baker Bros. Advisors | 2.1M | $1.9M | -18% | Dec 2023 |
|
| Redmile Group | 1.6M | $1.4M | 0% | Dec 2023 |
|
| Point72 Asset Management | 1.4M | $1.3M | 0% | Dec 2023 |
|
| Citadel Advisors | 109k | $96k | 88% | Dec 2023 |
|
| Virtu Financial | 40k | $35k | 100% | Dec 2023 |
|
| Millennium Management | 31k | $28k | 90% | Dec 2023 |
|
| Bank of America Corporation | 23k | $20k | -69% | Dec 2023 |
|
| Two Sigma Securities | 15k | $13k | 100% | Dec 2023 |
|
| Global Retirement Partners | 2.0k | $2.5k | -33% | Mar 2024 |
|
| Jpmorgan Chase & Co | 989.00 | $879.023200 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 35.00 | $0 | 0% | Dec 2023 |
|
Who sold out of Achilles Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Coppell Advisory Solutions | Sep 2023 | 1.0k | $5.6k |